TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $13.00
TG Therapeutics (NASDAQ:TGTX – Free Report) had its target price boosted by The Goldman Sachs Group from $12.00 to $13.00 in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. TGTX has been the topic of several other research reports. JPMorgan […]
More Stories
The Witness, TV Series: Release Date, Cast, Trailer, and Plot
Netflix’s upcoming documentary and television series are based on the real-life murder of Rachel Nickell in 1992. The Witness is...
15+ Famous White Actresses Over 40 Dominating the Film Industry
Want to know about popular white actresses over 40? Here, in this blog, I have mentioned some of the best...
Netflix Has Revealed The Release Date of The Thai Drama, The Evil Lawyer
Thailand’s upcoming courtroom drama, The Evil Lawyer, will be released soon. Netflix has announced the release date. The series features...
How to Build Your First Mobile App: A Step-by-Step Guide
Discover the essential steps in mobile app development, from defining your app idea to deploying and maintaining your application. This...
Essential Tips to Optimize Your Laptop for Maximum Performance
Enhance your laptop's performance with essential strategies covering hardware components, regular maintenance, and effective software management. Discover how upgrading your...
Discover the Essentials of Blockchain Technology: An In-Depth Guide
Discover the transformative power of blockchain technology in our comprehensive guide. Explore its fundamental components, operational mechanisms, and various applications...